Clinical trial
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
NCT00022035 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00022035 |
|---|---|
| Title | Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia |
| Official title | Influenza Vaccine Immunogenicity in Children During and After Therapy for Acute Lymphoblastic Leukemia |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Infection, Leukemia |
| Intervention type | Biological |
| Interventions | trivalent influenza vaccine |
| Start date | Aug 1, 2000 |
| Primary completion | Nov 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: